The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.
Eli Lilly and Company has completed its acquisition of Prevail Therapeutics, a New York-based company developing gene therapies, in a $1.04-billion deal ($880 million upfront plus one non-tradable contingent value right worth up to $160 million)....
Janet Woodcock, M.D., formerly head of the Center for Drug Evaluation and Research at the US Food and Drug Administration (FDA), was named Acting FDA Commissioner, effective January 20, 2021. She took over from Dr. Stephen Hahn, who served as the...
A roundup of news from Africa (Novartis, GSK), Germany (J&J), South Korea (Samsung Bioepis), and the US (Amgen, Pfizer, Moderna, Biogen, BI, AbbVie, and the FDA).
Africa
Novartis, GSK in $3.8-M Pact for Genetic Diversity Research Novartis and...
Civica Rx, a non-profit pharmaceutical company providing drugs in shortage, has announced a $124.5-million investment to build a 120,000-square-foot sterile injectable manufacturing facility in Petersburg, Virginia.
Civica Rx was established in...
The latest on manufacturing and potential treatments for COVID-19 with news from Sanofi, Moderna, Pfizer, AstraZeneca, Merck & Co., GlaxoSmithKline, Lilly, and others.
Manufacturing and supply of COVID-19 vaccines and drugs
Sanofi To...
An upcoming DCAT webinar this coming Tuesday Jan. 26, will provide thought leadership on what pharma companies, CDMOs/CMOs and other suppliers need to consider to further mitigate supply risk post COVID-19.
The COVID-19 pandemic has placed new...
The latest on manufacturing, potential treatments, and testing for COVID-19 with news from Pfizer, AstraZeneca, Lilly, Sinovac, Grifols, and Abbott.
Manufacturing and supply of COVID-19 vaccines and drugs
Pfizer, BioNTech Provide Mfg, Delivery...
The European Commission (EC) is calling on its 27 member states to accelerate the rollout of COVID-19 vaccinations across the European Union (EU) with targets set for March 2021 and the summer of 2021.
In a communication document issued...
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company, and Merus, a Utrecht, The Netherlands-based clinical-stage oncology company developing multi-specific antibodies, have announced a research collaboration and...
The latest on manufacturing and potential treatments for COVID-19 with news from Pfizer, Moderna, J&J, GSK, Novavax, Alexion, CureVac, and others.
Manufacturing and supply of COVID-19 vaccines and drugs
EU In Talks to Purchase More Doses of...
Regeneron Pharmaceuticals, a Tarrytown, New York-based biopharmaceutical company, has announced that the US government has agreed to purchase additional supply of its antibody cocktail (consisting of casirivimab and imdevimab) for treating...
Sanofi has agreed to acquire Kymab, a Cambridge, UK-based biopharmaceutical company, in a $1.45-billion deal ($1.1 billion upfront and up to $350 million in milestones).
Kymab’s lead product is KY1005, in Phase IIa development, for treating atopic...
Sanofi has chosen the name EUROAPI for its new European company dedicated to the development, production and marketing of active pharmaceutical ingredients (APIs).
Sanofi announced the formation of the standalone company in February 2020. The new...
Novartis has signed a strategic collaboration agreement to in-license from BeiGene, a Beijing-based pharmaceutical company, in major markets outside of China, tislelizumab, a drug for treating classical Hodgkin’s lymphoma and metastatic urothelial...
Regeneron Pharmaceuticals, a Tarrytown, New York-based biopharmaceutical company, has filed a lawsuit against the US government for a recently issued drug-pricing rule that uses a Most Favored Nation (MFN) drug-payment model that would set the...
